Patrice Garcia

Patrice Garcia

Auto-generated profile, based on publicly available information

Patrice Garcia

GIE LCH, Laboratoire des Courses Hippiques Verrières‐le‐Buisson France

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
PTPierre-Louis Toutain
Pierre-Louis Toutain
NRNadège Reymond
Nadège Reymond
VLValérie Laroute
Valérie Laroute
PGPatrice Garcia
Patrice Garcia
MPMarie-Agnès Popot
Marie-Agnès Popot
RNRüdiger Narbe
Rüdiger Narbe
Objective—To determine pharmacokinetic parameters for meloxicam, a nonsteroidal anti-inflammatory drug, in horses. Animals—8 healthy horses. Procedure—In the first phase of the study, horses were administered meloxicam once in accordance with a 2 × 2 crossover design (IV or PO drug administration; horses fed or not fed). The second phase used a multiple-dose regimen (daily oral administration of meloxicam for 14 days), with meloxicam administered at the recommended dosage (0.6 mg/kg). Plasma and urine concentrations of meloxicam were measured by use of validated methods with a limit of quantification of 10 ng/mL for plasma and 20 ng/mL for urine. Results—Plasma clearance was low (mean ± SD; 34 ± 0.5 mL/kg/h), steady-state volume of distribution was limited (0.12 ± 0.018 L/kg), and terminal half-life was 8.54 ± 3.02 hours. After oral administration, bioavailability was nearly total regardless of feeding status (98 ± 12% in fed horses and 85 ± 19% in nonfed horses). During once-daily administration for 14 days, we did not detect drug accumulation in the plasma. Meloxicam was eliminated via the urine with a urine-to-plasma concentration that ranged from 13 to 18. Concentrations were detected for a relatively short period (3 days) after administration of the final daily dose. Conclusions and Clinical Relevance—Results of this study support once-daily administration of meloxicam regardless of the feeding status of a horse and suggest a period of at least 3 days before urine concentrations of meloxicam reach concentrations that could be used in drug control programs. (Am J Vet Res 2004;65:1542–1547)

1 August 2011 in Analytica Chimica Acta
Verified
Journal Article
Closed access
YMYves Moulard
Yves Moulard
LBLudovic Bailly-Chouriberry
Ludovic Bailly-Chouriberry
SBSophie Boyer
Sophie Boyer
PGPatrice Garcia
Patrice Garcia
MPMarie-Agnès Popot
Marie-Agnès Popot
YBYves Bonnaire
Yves Bonnaire

2 September 2010 in Metabolomics
Verified
Journal Article
Closed access
PDF file
FKFanny Kieken
Fanny Kieken
GDGaud Dervilly
Gaud Dervilly
JAJean-Philippe Antignac
Jean-Philippe Antignac
APAnne-Christelle Paris
Anne-Christelle Paris
PGPatrice Garcia
Patrice Garcia
BBBruno Le Bizec
Bruno Le Bizec

28 December 2010 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
PGP. Garcia
P. Garcia
APA.‐C. Paris
A.‐C. Paris
JGJ. Gil
J. Gil
MPM.‐A. Popot
M.‐A. Popot
YBY. Bonnaire
Y. Bonnaire

27 June 2011 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
FBFanny Boyard‐Kieken
Fanny Boyard‐Kieken
GDGaud Dervilly
Gaud Dervilly
PGPatrice Garcia
Patrice Garcia
APAnne‐Christelle Paris
Anne‐Christelle Paris
MPMarie‐Agnès Popot
Marie‐Agnès Popot
YBYves Bonnaire
Yves Bonnaire

25 September 2008 in Analytical Chemistry
Verified
Journal Article
Closed access
LBLudovic Bailly-Chouriberry
Ludovic Bailly-Chouriberry
GDGaud Dervilly
Gaud Dervilly
PGPatrice Garcia
Patrice Garcia
MPMarie-Agnès Popot
Marie-Agnès Popot
BBBruno Le Bizec
Bruno Le Bizec
YBYves Bonnaire
Yves Bonnaire